Update cookies preferences

Ozempic gets green light for diabetes in India, Mystery illness kills 14 kids in Nagpur, Chhindwara Sélection

Lowdown93
0
378 Vues

0   0

In this segment of 5 Live, the focus is on the Indian drug regulator CDSCO's approval of the blockbuster drug Ozempic. It is cleared for treating type 2 diabetes and reducing risks of serious heart and kidney problems, but explicitly not for weight loss.


Publié Oct 01,2025

Catégorie Vidéo  /  News

Mots clés ozempic semaglutide cdsco type 2 diabetes weight loss heart disease kidney disease novo nordisk dr rajesh rajput acute encephalitis syndrome aes nagpur chhindwara dr nihar parikh glp-1 national institute of virology national center for disease control

Voir plus
Commentaires
Commentaires
Facebook
Disqus

0 Commentaires

    Les médias Suivant
    Médias liés
    Plus de cet utilisateur
    Privacy Settings